Tregs recruitment occurs through the binding of CCR4 on Tregs surface and CCL22 secreted by GBM tumour cells and CD163+ TAMs, under the induction of tumour-derived CCL20 and osteoprotegerin [59,60]. The gene discussed is TNFRSF11B; the disease is neoplasm.